The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Yasminelle 0.02 mg/3 mg film-coated tablets

0.02 / 3 milligram(s) Film-coated tablet

Bayer LimitedPA1410/024/001

Main Information

Trade NameYasminelle 0.02 mg/3 mg film-coated tablets
Active SubstancesEthinylestradiol (as betadex-clathrate)
Drospirenone
Strength0.02 / 3 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderBayer Limited
Licence NumberPA1410/024/001

Group Information

ATC CodeG03AA Progestogens and estrogens, fixed combinations
G03AA12 drospirenone and ethinylestradiol

Status

Authorised/WithdrawnAuthorised
Licence Issued24/07/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

« Back